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Development of a novel
immunochromatographic lateral flow assay
specific for Mycobacterium bovis cells and
its application in combination with
immunomagnetic separation to test badger
faeces
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Abstract
Background: The European badger is an important wildlife reservoir of Mycobacterium bovis implicated in the spread
of bovine tuberculosis in the United Kingdom and Ireland. Infected badgers are known to shed M. bovis in their urine
and faeces, which may contaminate the environment. To aid bovine tuberculosis control efforts novel diagnostic
tests for detecting infected and shedding badgers are needed. We proposed development of a novel, rapid
immunochromatographic lateral flow device (LFD) as a non-invasive test to detect M. bovis cells in badger faeces.
Its application in combination with immunomagnetic separation (IMS) to detect Mycobacterium bovis cells in badger
faeces is reported here.
Results: A novel prototype LFD for M. bovis cells was successfully developed, with unique specificity for M. bovis
and a limit of detection 50% (LOD50%) of 1.7 × 10
4 M. bovis cells/ml. When IMS was employed to selectively capture and
concentrate M. bovis cells from badger faeces prior to LFD testing, the LOD50% of the IMS-LFD assay was 2.8 × 10
5 M.
bovis cells/ml faecal homogenate. Faeces samples collected from latrines at badger setts in a region of endemic bovine
tuberculosis infection were tested; 78 (18%) of 441 samples tested IMS-LFD assay positive, whereas 140 (32%)
tested IMS-qPCR positive (Kappa agreement −0.009 ± 0.044, p = 0.838). Subsequently, when 130 faeces samples
from live captured, or captive, badgers of known infection status (on the basis of StatPak, interferon-γ and/or
culture results) were tested, the IMS-LFD assay had higher relative diagnostic specificity (Sp 0.926), but poorer
relative diagnostic sensitivity (Se 0.081), than IMS-qPCR (Sp 0.706, Se 0.581) and IMS-culture (Sp 0.794, Se 0.436).
Conclusions: The novel IMS-LFD assay, although very specific for M. bovis, has low analytical sensitivity (indicated
by the LOD50%) and would only detect badgers shedding high numbers of M. bovis (>10
4–5 cells/g) in their faeces. The
novel LFD would, therefore, have limited value as a non-invasive test for badger TB surveillance purposes but it may
have value for alternative veterinary diagnostic applications.
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Background
Mycobacterium bovis is the causative agent of bovine
tuberculosis (TB) in cattle, badgers and other wild and
domestic mammals [1]. Bovine TB is the most serious
endemic disease currently facing the livestock industry
in the United Kingdom and Republic of Ireland [2].
Despite a systematic test and slaughter programme in
cattle, which has been ongoing for many years within
the United Kingdom, the incidence of bovine TB has
continued to rise. This lack of success has been attributed
in part to the presence of a reservoir of infection in the
European badger (Meles meles) [3, 4]. Investigation of the
dynamics of TB in wildlife and cattle herds using DNA
fingerprinting of strains [5, 6] has revealed that badgers
and cattle tend to have similar M. bovis spoligotypes,
providing evidence of cross-species transmission [7]. In
parts of the United Kingdom, herd incidence rates of
TB in cattle more than doubled between 1998 and
2010, and although prevalence varies widely in badger
populations, estimates of 6.3–33.9% infection (depending
on county, overall 16.6%) were recorded in 2005 in
endemic areas [3]. The ability to identify and monitor
TB infection in the reservoir wildlife host may provide
a valuable tool for targeting efforts to control risks of
M. bovis transmission to cattle.
It is known that badgers can transmit M. bovis to
cattle [8], but the precise route of transmission is unclear.
A potential route if badgers and cattle come into close
proximity is inhalation of aerosolised droplets; however,
infected badgers are also known to shed M. bovis in their
urine and faeces [9, 10], which may contaminate the envir-
onment. Badgers habitually defecate in clusters of shallow
pits known as latrines which if accessible to cattle may act
as a possible source of infection [11]. Infected badgers are
known to intermittently shed M. bovis in their faeces in
variable numbers. For example, King et al. [12] demon-
strated heterogeneity in bacterial load for badgers in the
Woodchester Park, Gloucestershire, study area, and re-
ported shedding of 1 × 103-4 × 105 M. bovis cells per g of
faeces. Faecal shedding is an indication of infectiousness,
with shedding correlating with animals exhibiting more
severe disease status [13].M. bovis can persist in the envir-
onment for several months under certain conditions [14].
This environmental signal of the presence of M. bovis in a
badger population was demonstrated by Courtenay et al.
[15] who showed that the detectability of the bacterium at
badger setts and latrines was strongly linked to the fre-
quency of excretion detected in live-sampled badgers.
The M. bovis infection status of badgers in a given area
may be assessed in various ways: by active surveillance
involving the capture, anaesthesia and use of blood tests
and microbiological culture of samples (invasive); by
collecting and analysing badger faeces or other environ-
mental samples (non-invasive); or, by the examination
of badger carcasses after road traffic accidents (RTA) and
tissue culture. The appropriate method to adopt depends
on the question being asked and the geographical scale for
which data are required. For example, RTA surveys have
been used to provide coarse prevalence (or even presence/
absence) data on a large geographical scale [16–19],
whereas live capture and collection of clinical samples
has been used to provide more detailed eco-epidemiological
data over smaller areas [20]. The collection of faecal samples
from latrines for TB surveillance in badgers has the potential
to be used on a variety of geographical scales.
Since it is known that some infected badgers excrete M.
bovis in their faeces [9, 10], we proposed the development
of an immunochromatographic lateral flow device (LFD)
and its use in combination with an existing immunomag-
netic separation (IMS) technique [21, 22] as a non-invasive
test for the presence of M. bovis. Immunochromatographic
assays are easy to use, cheap to produce, and provide a
rapid result (within 15 min), so are ideal for field use. The
purpose of including IMS was to selectively capture and
concentrate target mycobacterial cells from the faeces
matrix before application to the LFD, to facilitate sample
clean-up and improve detection sensitivity. Here, we report
the successful development of a prototype M. bovis-specific
LFD and its application in combination with IMS to test
for evidence of M. bovis cells in badger faeces. We also
assessed agreement between results of the field IMS-LFD
assay and laboratory IMS-based methods (IMS-qPCR and
IMS-culture) when faeces from badgers of unknown infec-
tion status were tested, and estimated relative diagnostic
sensitivity (Se) and specificity (Sp) of the IMS-LFD assay by
testing faeces from badgers for which we had independent
information on their M. bovis infection status.
Methods
Bacterial cultures employed in the study
Mycobacterium bovis AF2122/97, M. bovis BCG NCTC
5692, M. avium subsp. avium NCTC 13034, M. avium
subsp. paratuberculosis ATCC 19698, M. fortuitum
NCTC 10394, M. intracellulare NCTC 10425, M. kansasii
NCTC 10268, M. xenopi NCTC 10042, M. terrae NCTC
10856, M. scrofulaceum NCTC 10803, M. marinum NCTC
2275, M. smegmatis mc2 155, M. gordonae NCTC 10267,
M. tuberculosis H37Rv, and a field isolate of M. hiberniae
were cultured in Middlebrook 7H9 broth containing 10%
OADC supplement (both Difco) to stationary phase,
harvested by centrifugation and washed in phosphate
buffered saline, pH 7.2 (PBS, Sigma). Cell suspensions
in PBS, containing 106–107 CFU/ml, were subjected to
a 10 kGy dose of gamma radiation using a Gammabeam
650 cobalt irradiator, in order to kill the bacteria without
damaging cell surface antigens and to render them safe to
use in a Containment Level 2 laboratory. Irradiated PBS
bacterial suspensions were stored at −80 °C until required.
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In addition, colonies of M. tuberculosis H37Rv grown on
solid agar were emulsified in PBS and 80 μl tested directly
on the LFD in a Containment Level 3 laboratory.
Development of a prototype lateral flow device (LFD)
specific for M. bovis
A selection of previously produced [21] or locally sourced
M. bovis-specific monoclonal and polyclonal antibodies was
tested for their suitability for incorporation into the pro-
posed LFD. In order to select the most appropriate anti-
bodies to serve as capture and detector reagents, a series of
trials were carried out. All the antibodies were conjugated
to gold nanoparticles and also all were immobilised at the
Test (T) line of different nitrocellulose membranes at
different concentrations. A cocktail of commercial anti-
mouse-IgG IgG and anti-rabbit-IgG IgG was immobilized
at the Control (C) Line position. A two-step wet assay was
performed to evaluate recognition of M. bovis whole cells
using the different combinations of membranes (with the
immobilized antibodies in the T Line) and gold conju-
gates. The combination of antibodies and membrane
which gave the strongest T-line was selected in order to
produce a batch of working prototype devices to be
evaluated.
Assessment of detection specificity and cross-reactivity of
the prototype LFD
PBS suspensions of the range of Mycobacterium spp.
identified above and six different spoligotypes of M.
bovis (SB140 (AF2122/97), SB129, SB273, SB142, SB263
and SB145) prepared as described above, were tested on
the prototype LFD. Irradiated cultures were vortexed
briefly before 80 μl were transferred to the sample well
of the LFD. The presence or absence of a T-line on the
LFD after 15 min at room temperature was assessed
visually in each case.
Determination of the limit of detection of the prototype
LFD
The 50% limit of detection (LOD50%) of the LFD was
determined by testing 10-fold serial dilutions of a
stock of irradiated M. bovis AF2122/97 (containing
5.3 × 106 CFU/ml) in PBS. Four replicate samples at
each of four dilutions containing 105, 104, 103 and
0 CFU/ml were tested. The presence or absence of a
T-line was assessed both visually and using an LFD
reader (Forsite Diagnostics Limited, York, UK) after
the sample had been run on the LFD for 15 min at
room temperature. The LOD50% was determined using
the generalized Spearman-Kärber LOD50% calculation
for 4-level spiking protocols [23].
Coating of magnetic beads for immunomagnetic
separation (IMS) and determination of M. bovis capture
sensitivity and bead specificity
The MyOne tosylactivated Dynabeads (Life Technologies,
Paisley, UK) previously used by Stewart et al. [22] for
immunocapture of M. bovis from bovine lymph node tissue
are 1 μm in diameter. These proved to be too large to run
along the LFD, so smaller carboxylated magnetic beads,
available in three sizes (200, 300 and 500 nm) were sourced
(Ademtech, France). All three sizes of Ademtech bead were
coated with the M. bovis-specific 11G3 monoclonal
antibody and EEA302 biotinylated peptide [21] separately,
and also with a mixture of the peptide and the antibody
(dually coated), using the Carboxyl-Adembeads Coupling
Kit (Ademtech 02820) according to the manufacturer’s in-
structions. Tenfold serial dilutions (10−1 to 10−5) of irradi-
ated M. bovis AF2122/97 (106–107 CFU/ml) were prepared
and 1 ml of each dilution was subjected to automated IMS
using the Dynal BeadRetriever (Life Technologies) (21)
using the different sized/coated Adembeads, with re-
suspension of the beads after IMS in 100 μl Tris-EDTA
(TE) buffer. After extraction of DNA by heating at 100 °C
for 25 min, the samples were analysed using M. bovis touch-
down PCR [24] and visualised using agarose gel electrophor-
esis PCR, as described in Stewart et al. [21]. As controls, and
to enable comparison of capture sensitivities achieved, dually
coated MyOne Tosylactivated Dynabeads (Life Technolo-
gies) and a dilution series of irradiated M. bovis AF2122/97
in TE buffer not subjected to IMS were included.
Specificity of the 200 and 300 nm coated beads was
assessed by IMS experiments involving the range of
Mycobacterium spp. described above. Each species was
tested on two separate occasions. Stationary phase broth
cultures of each species were diluted to 103–104 CFU/ml
in Middlebrook 7H9/OADC broth. A 100 μl sample of
the dilutions was spread onto Middlebrook 7H10/OADC
agar plates to determine CFU/ml before IMS and 1 ml of
each dilution was then subjected to automated IMS using
each of the coated beads. Following IMS, beads were
resuspended in 1 ml Middlebrook 7H9/OADC broth
(maintaining original sample volume in order to permit
direct comparison of colony counts before and after
IMS), 100 μl of which was spread onto Middlebrook
7H10/OADC agar plates. Agar plates were incubated at
30, 37 or 42 °C (as appropriate for the Mycobacterium
sp. concerned) until colonies were evident. Mean col-
ony count following IMS was expressed as a percentage
of the number of CFU present in the original suspen-
sion before IMS to calculate the degree of non-specific
binding by Mycobacterium spp. other than M. bovis.
Optimisation of faeces sample preparation protocol
Optimisation of the faeces sample preparation protocol
is described in detail elsewhere [25]. Briefly, a number of
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factors in relation to application of IMS in the field
needed to be considered before arriving at a finalised
field IMS protocol. These included the volume of diluent
required to homogenise the faecal samples, the effect of
the faecal matrix on bead retrieval, the time needed to
retrieve the beads, the dilution factor required, the quan-
tity of beads required, the assessment of matrix effect on
capture of M. bovis by coated beads, and the effect of
nylon strainers on the recovery of M. bovis.
Limit of detection of IMS-LFD assay applied to faeces
The LOD50% of the IMS-LFD assay was determined
twice using two different M. bovis negative badger faeces
samples as the spiking matrix. Four replicate samples
were spiked at four cell concentrations (105, 104, 103 and
0 CFU/ml) before the field IMS-LFD assay was applied.
The presence or absence of T-lines was assessed visually.
The LOD50% was, once again, estimated using the gener-
alized Spearman-Kärber LOD50% calculation for 4-level
spiking protocols [23].
Ability of the novel IMS-LFD assay to detect M. bovis in
naturally infected badger faeces
Badger faeces samples were collected from latrines at 110
setts throughout Northern Ireland. A random sample of
1 km squares containing main setts, located during the
Northern Ireland Badger Survey 2007/08 [26], were
selected to be visited for sampling purposes. These setts
were located in geographic areas with high, moderate
and low reported incidence of tuberculosis breakdowns
in cattle, based on information supplied by the Department
of Agriculture and Rural Development for Northern
Ireland. On arrival at each main sett, a single latrine was
located from which up to a maximum of five of the freshest
appearing faecal samples were collected; each sample was
taken from a different dropping.
The IMS-LFD procedure was performed in the field as
summarised schematically in Fig. 1. Approximately 1 g
of badger faeces was transferred to a tube containing
9 ml PBS pH 7.2 and the sample was shaken vigorously by
hand. When a homogeneous suspension was obtained, the
sample was filtered through a 70 μm cell strainer (Falcon)
into a 50 ml centrifuge tube. A sub-sample of 6–8 ml of
this homogenised, filtered faeces sample was poured into
a tube containing 20 μl of antibody- and peptide- dually
coated 300 nm carboxylated magnetic beads. The sample
was incubated at ambient temperature for 30 min and
shaken every 5 min. The tube was placed in a DynaMag™-
15 magnetic rack (Life Technologies) for 10 min before
the supernatant was carefully poured off, leaving the beads
behind. Beads were washed three times by shaking in
approx. 5 ml PBS-0.05% Tween 20 (PBS-T, Sigma) per
wash with separation for 2 min on the magnetic rack
between washes. After the third wash the beads were
resuspended in 200 μl Detector™ block solution (KPL Inc.,
Gaithersburg, USA) and 80 μl was transferred to the test
well of the LFD. After 15 min the IMS-LFD result was re-
corded as ‘positive’ if both Control (C) and Test (T) lines
were visible or ‘negative’ if only the C line was observed.
Digital photographs were taken to record test outcomes.
The LFDs were retained and returned to the laboratory
where the presence of a T line was subsequently verified
using a Forsite LFD reader. Residual bead suspensions
were also returned to the laboratory for Ziehl-Neelsen
staining and examination by light microscopy, in order to
verify the presence of large numbers of acid-fast cells in
samples which had tested IMS-LFD positive in the field.
Laboratory IMS-based tests on residual faecal
homogenates
The residual 1–2 ml portion of each homogenised, filtered
badger faecal sample was returned to the laboratory where
automated IMS followed by real-time qPCR (IMS-qPCR)
and MGIT™ culture (IMS-culture) were carried out. One
ml of each homogenised, filtered badger faecal sample was
subjected to automated IMS with dually antibody- and
peptide-coated MyOne tosylactivated Dynabeads [21] using
a Dynal BeadRetriever (both Life Technologies). Following
automated IMS, the beads plus any captured M. bovis cells
were resuspended in 500 μl Middlebrook 7H9 broth which
was then split between a 100 μl sample for qPCR (method
of Sweeney et al. [27]) and 400 μl for BACTEC™ MGIT™
culture (Becton Dickinson). DNA was released from bead-
bound M. bovis cells by boiling for 25 min and then puri-
fied by Zymoclean columns (ZymoResearch) before qPCR
was performed using an Eco-PCR instrument (Illumina,
Inc.). The reaction volume was 25 μl comprising 12.5 μl of
TaqMan Gene expression ×2 master mix (Life Tech-
nologies), 1 μl (20 pmol/μl) forward RD4 flanking pri-
mer (5′ TGTGAATTCATACAAGCCGTAGTCG 3′),
1 μl (20 pmol/μl) reverse RD4 flanking primer (5′
CCCGTAGCGTTACTGAGAAATTGC 3′), 1 μl
(10 pmol/μl) RD4 hydrolysis probe (5′ 6-FAM–AGCG
CAACACTCTTGGAGTGGCCTAC–MGB 3′), 7 μl of
nuclease-free sterile water and 2.5 μl of template
DNA. The RD4 hydrolysis probe and qPCR primers
were purchased from Life Technologies. Reaction con-
ditions were: 50 °C for 2 min, 95 °C for 10 min, and
40 cycles of 95 °C for 15 s and 60 °C for 1 min. Dupli-
cate 2.5 μl aliquots of DNA were tested for each faecal
sample. Both aliquots had to report positive or nega-
tive for a definitive IMS-qPCR result to be recorded.
In instances where there was disagreement between
the duplicate results for any sample, the qPCR was re-
peated. If disagreement between duplicate results still
existed after the second PCR then the sample was
recorded as IMS-qPCR negative (interpretation adopted
by Travis et al. [28]). A six point standard curve, generated
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using DNA from a dilution series (106–10 CFU/ml) of
irradiated M. bovis AF2122/97, and a no template control
(water only), were run in duplicate in each qPCR run.
For IMS-culture, after IMS the beads (400 μl) were
inoculated directly into BACTEC™ MGIT™ culture tubes
supplemented with 10% OADC supplement and PANTA
antibiotic supplement (all Becton Dickinson). The MGIT
cultures were observed visually (because no MGIT 960
instrument was available in the laboratory) at intervals
over an incubation period of up to 12 weeks at 37 °C for
signs of growth (turbidity change). After 4, 8 and 12 weeks
of incubation 100 μl of each MGIT culture showing evi-
dence of growth was removed, boiled at 100 °C for 25 min
and checked for presence of M. bovis DNA by Touch-
down PCR targeting the IS6110 element and employing
INS1 and INS2 primers [24]. The Touchdown PCR was
able to detect down to 50 M. bovis CFU/ml (Stewart and
Grant, unpublished data). An IMS-culture positive result
was declared if MGIT cultures showing evidence of
growth (turbidity) tested Touchdown PCR positive. If no
growth was observed after 12 weeks or if the final Touch-
down PCR results for the MGIT positive cultures at
12 weeks were all negative, then a negative IMS-culture
result was declared.
Assessment of the diagnostic specificity and sensitivity
of the IMS-LFD assay by testing faeces from badgers of
putative known infection status
In total, 130 faecal samples were collected from badgers
for which independent live animal TB diagnostic test
results were also available. The samples were tested by
the IMS-LFD assay, IMS-qPCR and IMS-culture, as
described above for the badger faecal samples collected
from latrines, except that sample preparation and the
IMS-LFD test were performed in the laboratory. Of the
130 faecal samples, 100 had been obtained, following
administration of an enema, from badgers trapped as
part of the long-term capture-mark-release project at
Woodchester Park, Gloucestershire, England. In order to
maximise the likelihood that a proportion of these sam-
ples came from M. bovis-infected animals, we targeted
collection at badger social groups with evidence of current
or recent live animal test positive results. Following
collection all faeces samples were stored at -70 °C for
up to 7 months prior to testing. BrockTB Stat-Pak®
(Chembio Diagnostic Systems, Inc., Medford, NY), culture
(of sputum, faeces, urine, wound/abscess swabs), and
interferon-gamma enzyme immunoassay (IFN-γ EIA
[29]) test results, obtained over the previous 1–2 years,
were available for these animals. The remaining 30
faecal samples were obtained from captive badgers that
were originally trapped in a part of the United Kingdom
with very low incidence of TB in cattle. These 30 bad-
gers had tested negative for M. bovis infection by the
IFN-γ EIA test and bacteriological culture of clinical
samples (sputum, urine and rectal swab) on three se-
quential occasions over a three month period. They
were, therefore, considered putative ‘non-infected’. All
130 faeces samples were blind tested by staff at Queen’s
University Belfast.
Fig. 1 Schematic outlining the field IMS-LFD testing procedure for testing badger faeces
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Statistical analysis
Descriptive statistics captured the prevalence of M. bovis
positive results using the three IMS-based tests (IMS-
LFD, IMS-qPCR and IMS-culture) on 441 badger faeces
of unknown disease infection status collected in North-
ern Ireland, and 130 badger faecal samples collected
from Woodchester Park (n = 100) and captive (n = 30)
animals for which contemporaneous or previous live animal
diagnostic test results were available. Venn diagrams were
prepared to illustrate inter-relationships between the results
obtained with each test. Cross-tabulation of results permit-
ted determination of Kappa statistics, as a measure of the
agreement between test results, which were interpreted
according to Landis and Koch [30]. McNemar’s test was
performed on 2 × 2 contingency tables of results for the
three IMS-based tests versus the badgers’ putative TB infec-
tion status derived on the basis of the live animal diagnostic
test results, to permit estimation of diagnostic sensitivity
(Se) and specificity (Sp) of the field IMS-LFD, IMS-qPCR
and IMS-culture tests applied to faeces. Since no gold
standard diagnostic test for M. bovis in badgers exists,
estimates of diagnostic specificity and sensitivity are
relative to the live animal tests applied. All statistical
analyses were performed using SPSS 21 (IBM), unless
otherwise stated.
Results
Development of a prototype M. bovis-specific LFD
A specific monoclonal mouse anti-M. bovis antibody
(Mab) and a rabbit anti-M. bovis polyclonal antibody
(Pab) were successfully conjugated to the gold nanoparti-
cles, and the resulting conjugates were found to be stable.
Potential capture reagents were immobilised at the T-line
position on the membranes and a cocktail of commercial
anti-mouse-IgG and anti-rabbit-IgG IgG was immobilized
at the C-line position. Following trials with different
combinations and concentrations of capture and detector
reagents, it was concluded that the working prototype
LFD for the detection of M. bovis whole cells was com-
prised of ‘membrane 1’ with polyclonal antibody immo-
bilised at the T-Line to act as the capture reagent and
Mab conjugated to gold nanoparticles to act as the
detector reagent. A batch of 1000 prototype LFDs was
produced by Forsite Diagnostics Ltd., York, for evaluation
at Queen’s University Belfast. For commercial reasons,
no additional detail about the membrane or antibodies
used for the prototype LFD device can be provided here.
When the detection specificity of the prototype LFD
was evaluated by testing a range of different Mycobac-
terium spp. diluted in PBS, the prototype LFD yielded
a positive T-line for M. bovis (all six spoligotypes
tested) and M. bovis BCG only (Fig. 2a), and gave a
negative T-line with all other Mycobacterium spp.
tested (Fig. 2b). In terms of detection sensitivity, the
LOD50% for M. bovis suspended in PBS was deter-
mined to be 1.7 × 104 M. bovis cells/ml.
IMS modification
Evaluation of the smaller Ademtech carboxylated mag-
netic beads indicated that, like the previously used MyOne
Tosylactivated beads, dually coated beads (i.e. coated with
both peptide and IgM antibody) produced the best M.
bovis capture results. The dually coated 300 nm and
200 nm beads showed similar capture capability from both
buffer and spiked faeces, with <3% non-specific binding
with all the other non-target mycobacteria tested. It was,
therefore, concluded that either sized bead could be used
with the LFD, and we decided to use the 300 nm beads.
Combining field IMS with the LFD
After field IMS the beads were resuspended in 200 μl
PBS for analysis on the LFD. However, it was found that
uncoated beads, coated beads and the storage buffer
recommended by Ademtech all produced a false posi-
tive T-line on the LFD after IMS. To resolve this issue
an extra step of quenching the activated unused carb-
oxyl groups present on the bead surface using ethanol-
amine was introduced during coating of the beads, and
various blocking solutions were investigated as alternatives
to the Ademtech storage buffer for resuspension of the
coated beads. The false positive issue was resolved by
resuspension of beads after IMS in KPL Detector™ block,
a commercially available blocking solution (KPL Inc.,
Gaithersburg, Maryland). The finalised field IMS-LFD
protocol was as illustrated in Fig. 1.
The LOD50% of the field IMS-LFD was estimated to be
2.8 × 105 M. bovis cells/ml faeces homogenate (1:10 dilu-
tion), so the detection sensitivity of the LFD was reduced
when IMS preceded LFD detection, and faeces homoge-
nates rather than PBS suspensions were being tested.
Capability of the IMS-LFD test to detect M. bovis in
badger faeces relative to the laboratory-based IMS-qPCR
and IMS-culture tests
A total of 441 badger faecal samples, collected from 110
main setts throughout Northern Ireland were tested. A
mean of four faeces samples were collected from a single
latrine at each main sett. Using the individual faecal
sample as the unit of analysis, 78 faecal samples (18%)
tested positive with the field IMS-LFD test, 140 (32%)
tested positive by IMS-qPCR, and 64 (15%) tested positive
by IMS-culture, with only three faecal samples (0.7%) test-
ing positive by all three tests (Fig. 3a). Given the LOD50%
of the IMS-LFD assay applied to badger faeces indicated
above, a positive result with this assay should indicate the
presence of ~105 M. bovis cells/ml, which should be vis-
ible microscopically. Acid-fast bacteria attached to the
magnetic beads were observed for several of the IMS-LFD
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positive faecal samples, providing confirmation that high
numbers of acid-fast bacteria (assumed to be M. bovis)
were indeed present when an IMS-LFD positive result was
obtained.
Field IMS-LFD results were compared with results of
the two laboratory IMS-based methods; neither of which
was being considered as the gold standard method for
detecting M. bovis in faeces. There was no significant
association between the results of field IMS-LFD,
IMS-qPCR or IMS-culture (P > 0.05). Kappa statistics
indicated ‘poor’ agreement between IMS-LFD and
IMS-qPCR results (Kappa = −0.009, 95% CI: -0.095 to
0.077, p = 0.838) and ‘slight’ agreement (Kappa = 0.045,
95% CI: -0.054 to 0.144, p = 0.342) between IMS-LFD
and IMS-culture results (Table 1A).
Estimation of the relative diagnostic specificity and
sensitivity of the IMS-LFD assay by testing faeces from
badgers of known infection status
The TB infection status of the 100 badgers from
Woodchester Park that had contributed the faecal samples
tested was only revealed to laboratory staff once results
became available for the IMS-based tests. The badgers
were categorised as putative ‘TB infected’ if a positive re-
sult had been obtained for Stat-Pak®, culture or IFN-γ EIA
tests on any test occasion previously, and as putative ‘non-
Fig. 2 Outcomes of specificity testing of the prototype lateral flow immunochromatographic device (LFD) demonstrating (a) the presence of a
positive T-line with Mycobacterium bovis AF2122/97, M. bovis BCG NCTC 5692 and five other M. bovis spoligotypes and (b) only the presence of a
C-line for all other Mycobacterium spp. tested
Fig. 3 Venn diagrams showing the numbers (percentage) of faeces samples that tested positive by field IMS-LFD, IMS-qPCR and IMS-culture from
441 badgers of unknown infection status collected from latrines at main setts in Northern Ireland (a) and from 100 live captured badgers and 30
captive putative TB negative badgers for which independent live animal diagnostic test data were available (b). Areas of overlap indicate positive
test results in common
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infected’ if a negative result had been obtained for all three
live animal tests on each previous testing occasion. Over-
all, there were 62 faecal samples from putative ‘TB in-
fected’ and 38 from putative ‘non-infected’ badgers in this
cohort. The field IMS-LFD tested positive for 10% of
faecal samples obtained by enema from these 100 live
captured badgers, whilst IMS-qPCR and IMS-culture
tested positive for 56% and 41% of samples, respectively.
Five (3.8%) samples tested positive by all three IMS based
tests (Fig. 3b). Two samples tested positive by the IMS-
LFD test and not by either of the other two IMS-based
tests. All of the 30 faeces from putative ‘non-infected’
captive badgers tested negative by field IMS-LFD, IMS-
qPCR and IMS-culture, so no false positive IMS-LFD
results were obtained. Overall, Kappa statistics indicated
‘poor’ agreement between IMS-LFD and IMS-qPCR re-
sults (Kappa = 0.129, 95% CI: 0.019 to 0.238, p = 0.014)
and also between IMS-LFD and IMS-culture results
(Kappa = 0.083, 95% CI: -0.056 to 0.221, p = 0.083) for
the 130 faeces samples tested (Table 1B).
Cross-tabulation of badger infection status (on the
basis of prior live animal diagnostic test results) with
IMS-LFD, IMS-qPCR and IMS-culture results (Table 2)
enabled estimates of relative diagnostic specificity (Sp)
and sensitivity (Se) to be obtained using McNemar’s test.
IMS-qPCR and IMS-culture had much higher diagnostic
Se (0.581 and 0.436, respectively) than the IMS-LFD test
(0.081) (Table 2). However, the IMS-LFD test had greater
diagnostic Sp (0.926) than either IMS-qPCR (0.706) or
IMS-culture (0.794) (Table 2).
Discussion
The IMS-LFD test described here was developed with a
view to it being a rapid and non-invasive test to detect
the presence of whole M. bovis cells in badger faeces. To
our knowledge, the prototype LFD developed is the first
of its kind. Other M. bovis LFDs are available commer-
cially, but these detect either serum antibodies to M.
bovis (BrockTB Stat-Pak® assay or DPP® CervidTB assay,
both Chembio Diagnostic Systems, Inc., Medford, NY),
or the MPT64 antigen secreted by members of the
Mycobacterium tuberculosis complex, which includes M.
bovis, in liquid culture (BD MGIT™ TBc Identification
Test, Becton, Dickinson and Company, NJ; SD Bioline
TB Ag MPT 64, Standard Diagnostics, Inc., Gyeonggi-do,
Republic of Korea; Capilia TB-Neo kit, TAUNS Laboratories,
Inc., Shizuoka, Japan). The unique specificity of the LFD
developed during this study is due to the particular mono-
clonal antibody conjugated to gold nanoparticles and used
as the detector reagent in the novel LFD; for commercial
reasons, no further details of this antibody can be provided.
The novel M. bovis-specific LFD was used in combination
with a modified IMS technique (involving smaller magnetic
beads) in order to capture and concentrate M. bovis cells
from the faeces matrix and remove gross faecal components
that could potentially block movement of the beads along
the LFD.
When 441 badger faeces samples collected from latrines
at main setts throughout Northern Ireland were tested by
the IMS-LFD assay, IMS-qPCR and IMS-culture, M. bovis
was detected in 18%, 32% and 15% of faecal samples re-
spectively (Fig. 3a). There was little agreement between
the results of the three IMS-based tests. Whilst the same
faecal homogenate was tested by all three methods, dif-
ferent volumes of material were tested in the field (by
IMS-LFD) and in the laboratory (by IMS-qPCR and
IMS-culture). Automated IMS in the laboratory was re-
stricted to analysing 1 ml of sample whereas the field
IMS was carried out on a 6–8 ml volume of filtered faecal
homogenate. We estimate that there was the equivalent
Table 1 Cross-tabulation of field IMS-LFD, IMS-qPCR and IMS-culture results for 441 badger faecal samples freshly collected
from latrines at main setts in Northern Ireland (A), and 130 faecal samples obtained from live captured or captive badgers of putative known
TB infection status (B)
(A)
Field test result Laboratory-based test results:
IMS-qPCR + IMS-qPCR - Kappa ± SE (significance) IMS- culture + IMS- culture - Kappa ± SE (significance)
IMS-LFD + 24 54 −0.009 ± 0.044 14 64 0.045 ± 0.051
IMS-LFD - 116 247 (p = 0.838 NS) 50 313 (p = 0.342NS)
Total 140 301 64 377
(B)
Field test result Laboratory-based test results:
IMS-qPCR + IMS-qPCR - Kappa ± SE (significance) IMS- culture + IMS- culture - Kappa ± SE (significance)
IMS-LFD + 8 2 0.129 ± 0.056 5 5 0.083 ± 0.063
IMS-LFD - 48 72 (p = 0.014*) 36 84 (p = 0.083NS)
Total 56 74 41 89
NS no significant association, * P<0.05, significant association at the 95% level
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of ~250 mg faeces per 80 μl bead sample applied to the
LFD after IMS in the field, ~5 mg faeces per IMS-
qPCR reaction, and ~80 mg faeces per IMS-culture (as-
suming no losses during sample processing), so the
higher volume of sample used for the IMS-LFD assay
may explain the few extra samples which tested positive
by the field IMS-LFD test (Fig. 3a). That said, we
estimated in preliminary studies [25] the LOD50% of
IMS-qPCR to be 1.7 × 104 M. bovis cells/ml of faeces
homogenate (or 1.7 × 105 M. bovis cells/g faeces), indi-
cating that the IMS-qPCR method should theoretically
have greater detection sensitivity than the field IMS-
LFD assay (which was found to have an LOD50% of
2.8 × 105 M. bovis cells/ml of faecal homogenate or
2.8 × 106 M. bovis cells/g faeces). This being the case,
more M. bovis positive faecal samples should have been
detected by IMS-qPCR than by IMS-LFD, which was
the situation during this study. Furthermore, differently
sized magnetic beads were used in the field and labora-
tory tests, because only the smaller (300 nm) coated
beads would pass along the LFD. Despite being coated
with the same M. bovis-specific binders, we know that
the 300 nm Ademtech beads have slightly less capture
capability than the 1 μm MyOne Tosylactivated Dyna-
beads; this may also have influenced results obtained for
the field IMS-LFD test compared to the laboratory IMS-
based tests. We also suspect, but cannot demonstrate, that
various environmental, logistical and practical consider-
ations may have influenced the faecal sample preparation
and IMS capture steps in the field, potentially leading to
non-optimal performance of the IMS-LFD test. Some or
all of these factors may have contributed to, and hence ex-
plain, the lack of agreement between field IMS-LFD and
laboratory IMS-based test results. Test results for badger
faeces collected from latrines at setts have demonstrated
for the first time that the novel LFD is capable of detecting
M. bovis cells in naturally contaminated badger faeces.
However, due to the lack of agreement between results of
the different IMS-based tests (Table 1A), with the lowest
number of M. bovis positive samples being detected by
IMS-LFD, results suggest that the novel IMS-LFD assay
would be of limited use for badger TB surveillance pur-
poses. Although the LFD was shown to have unique speci-
ficity for M. bovis (Fig. 2), the analytical sensitivity
indicated by the LOD50% of the combined IMS-LFD assay
(2.8 × 105 M. bovis cells/ml faecal homogenate) means
that only badgers shedding high numbers of M. bovis in
their faeces would be detected, and infected badgers shed-
ding lower numbers of M. bovis would test negative by the
IMS-LFD assay. Given its reasonably high LOD50%, the
novel IMS-LFD test may be more suited for applications
where high numbers of M. bovis would be encountered,
such as confirming the isolation of M. bovis from animal
tissues in liquid cultures in the veterinary diagnostic
laboratory context. This possibility is currently being
investigated.
The ability of a novel diagnostic test to correctly iden-
tify infected and non-infected animals is an important
consideration, so in order to determine the relative diag-
nostic sensitivity and specificity of the novel IMS-LFD
assay, we tested 130 faeces samples from badgers for
which independent diagnostic test results were available.
Of these, the IMS-LFD tested positive in 10 (7.7%) cases,
whilst 56 (43.0%) and 41 (31.5%) samples tested positive
by IMS-qPCR and IMS-culture, respectively (Fig. 3a).
Test results for the subset of 30 faeces samples from
putative TB negative captive badgers indicated that all
samples were IMS-LFD, IMS-qPCR and IMS-culture
negative; thus providing evidence of the high relative
specificity of the novel IMS-LFD test, and indeed the
other two IMS-based tests. The IMS-LFD test was found
to have high diagnostic Sp (0.926) but low diagnostic Se
(0.018), relative to the comparator live animal diagnostic
tests, indicating an inability to detect low numbers of M.
bovis cells in faeces, whereas IMS-qPCR and IMS-culture
had lower diagnostic Sp (0.706 and 0.794, respectively)
Table 2 Estimates of the diagnostic specificity (Sp) and sensitivity (Se) of the field IMS-LFD and laboratory-based IMS-qPCR and
IMS-culture tests for M. bovis in faeces from 100 live captured badgers and 30 live captive badgers relative to live diagnostic test
results, obtained using McNemar’s test (95% confidence intervals are indicated in parentheses)
Test result Putative TB infected Putative Non-infected Total Diagnostic sensitivity, Se Diagnostic specificity, Sp
IMS-LFD + 5 5 10 0.081 0.926
IMS-LFD - 57 63 120 (0.027–0.178) (0.837–0.976)
62 68 130
IMS-qPCR + 36 20 56 0.581 0.706
IMS-qPCR - 26 48 74 (0.449–0.705) (0.583–0.811)
62 68 130
IMS-culture + 27 14 41 0.436 0.794
IMS-culture - 35 54 89 (0.310–0.567) (0.678–0.882)
62 68 130
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but higher diagnostic Se (0.581 and 0.436, respectively). It
is acknowledged that potential mis-classification of the TB
infection status of the badgers in our study due to false
negative live animal test results may have impacted our
estimates of the sensitivity and specificity of IMS-based
tests (Table 2), so the latter should be treated with caution
and only as relative measures of test performance.
The percentages of badger faeces samples from
Woodchester Park testing M. bovis positive by IMS-qPCR
and IMS-culture reported here appear relatively high.
However 62 of the 100 faeces samples we tested were
from putative ‘TB infected’ badgers with at least one pre-
vious positive live animal test result. Hence the 8.1%, 58%
and 43.5% which tested IMS-LFD, IMS-qPCR and IMS-
culture positive, respectively, could be considered as the
percentage of M. bovis faecal positives amongst putative
‘TB infected’ badgers only. However, it is notable that the
presence of M. bovis was also indicated by one or more of
the IMS-based tests in 25 (65.8%) of 38 faeces samples
from putative ‘non-infected’ badgers (Fig. 4). This was un-
expected since faecal shedding of M. bovis by badgers has
been generally associated with advanced disease [9], and
may be intermittent and heterogeneous [12]. It is possible
that some of these putative ‘non-infected’ badgers were
misclassified as such owing to limitations in live test per-
formance [31]. Also, in the cases of the IMS-LFD and
IMS-qPCR tests, positive results could have arisen from
the detection of dead M. bovis cells originating from the
environment and not indicative of infection, although an
IMS-culture test positive result requires mycobacterial
growth and so indicates the presence of live viable bac-
teria. In conclusion, the present study was not designed to
provide estimates of the proportion of badgers shedding
viable M. bovis in their faeces, rather to test the perform-
ance of novel non-invasive tests, nevertheless our results
suggest that further investigation of the extent of faecal
shedding in badgers is warranted.
In this study, M. bovis cells were concentrated and
selectively captured by IMS from several millilitres of
an homogenate of approximately 1 g faeces in PBS in
advance of detection by LFD, qPCR and culture during
this study; a testing approach that has never been used
before on badger faeces. The traditional badger faeces
testing approach would be to decontaminate faecal sus-
pensions in PBS with 0.75% cetylpyridinium chloride
overnight prior to culture in liquid and/or solid media
[10] or to extract total community DNA from approxi-
mately 0.1 g faeces prior to M. bovis-specific qPCR [12].
By testing a larger quantity of faeces, selectively isolating
M. bovis cells prior to DNA extraction as well as separat-
ing them from PCR inhibitors by IMS, and not employing
chemical decontamination which is known to have an
adverse impact on the viability of M. bovis cells [32, 33],
the chances of detection/isolation of M. bovis from faeces
were likely to have been improved. The three IMS-based
methods do not have equivalent detection sensitivity, so it
is not surprising that the least sensitive test (IMS-LFD
assay) detected lower numbers of M. bovis positive
faecal samples than both IMS-qPCR and IMS-culture
(Fig. 3a and b). Stewart et al. [22] previously reported
that IMS-qPCR and IMS-culture improved detection
rates of M. bovis in cattle lymph nodes compared to
direct qPCR and chemical decontamination and culture.
Results of the present study suggest that a similar boost in
M. bovis detection rates has generally been observed by
applying these IMS-based methods to test badger faeces.
IMS applied to faeces samples in advance of application to
the LFD should in theory have improved the detection
sensitivity of the LFD, since M. bovis cells were concen-
trated from 6 ml faecal homogenate into 200 ul before
testing. In reality, despite the fact that smaller (300 nm)
paramagnetic beads were employed, samples after field
IMS on faeces samples did not always run easily along the
LFD due to bead aggregation. Consequently, detection
sensitivity actually decreased and this was not simply due
to a sample matrix effect. Results of a subsequent ring trial
study to compare IMS-LFD and direct LFD with other
methods for detecting M. bovis in badger faeces showed
that fewer positive results were obtained after IMS than
by direct LFD testing [34].
Fig. 4 Relationships between the IMS-based test results for 100
faeces samples from badgers in the Woodchester Park study area
and the M. bovis infection status of these badgers as indicated by
results of contemporaneous or previous Stat-Pak®, culture and
Interferon-gamma tests
Stewart et al. BMC Veterinary Research  (2017) 13:131 Page 10 of 12
Conclusions
A novel prototype M. bovis-specific LFD was successfully
developed which, in combination with IMS, was shown to
be capable of detecting M. bovis cells in some badger faeces
samples tested during this study. However, there was gener-
ally little agreement between results of field IMS-LFD and
laboratory-based IMS-qPCR and IMS-culture tests; the
IMS-LFD assay detected the lowest percentage of M.
bovis-infected badger faecal samples, reflective of its
higher LOD50%. The novel IMS-LFD test was shown to
have relatively high diagnostic Sp (0.926, 95% CI:
0.837–0.976) but low diagnostic sensitivity (0.081, 95%
CI: 0.027–0.178), relative to a suite of other live animal
diagnostic tests. In light of these findings, the potential
of the novel IMS-LFD test for M. bovis in badger faeces
as a non-invasive field test for badger surveillance pur-
poses would appear to be potentially limited to detecting
badgers shedding high numbers of M. bovis (≥105 CFU/g)
in their faeces. Alternative applications for the novel M.
bovis-specific LFD are currently being explored.
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